BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33716791)

  • 1. The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling.
    Lai J; Chen C
    Front Physiol; 2021; 12():642470. PubMed ID: 33716791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
    Xu X; Zhang XA; Wang DW
    Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P; Siest G; Visvikis-siest S
    Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inside epoxyeicosatrienoic acids and cardiovascular disease.
    Tacconelli S; Patrignani P
    Front Pharmacol; 2014; 5():239. PubMed ID: 25426071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally Active Epoxyeicosatrienoic Acid Analogs.
    Campbell WB; Imig JD; Schmitz JM; Falck JR
    J Cardiovasc Pharmacol; 2017 Oct; 70(4):211-224. PubMed ID: 28937442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs.
    Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X
    Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
    Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury.
    Imig JD
    Adv Pharmacol; 2022; 94():27-55. PubMed ID: 35659375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
    Aliwarga T; Dinh JC; Heyward S; Prasad B; Gharib SA; Lemaitre RN; Sotoodehnia N; Totah RA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epoxyeicosatrienoic acid analogs and vascular function.
    Sudhahar V; Shaw S; Imig JD
    Curr Med Chem; 2010; 17(12):1181-90. PubMed ID: 20158473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
    Karkhanis A; Tram NDT; Chan ECY
    Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
    Deng Y; Theken KN; Lee CR
    J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Epoxyeicosatrienoic Acids in Cardiomyocytes-Specific CYP2J2 Transgenic Mice Are Associated with Improved Myocardial Remodeling.
    Aliwarga T; Guo X; Evangelista EA; Lemaitre RN; Sotoodehnia N; Gharib SA; Zeldin DC; Liu Q; Totah RA
    Biomedicines; 2020 May; 8(6):. PubMed ID: 32486275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.
    Shahabi P; Siest G; Meyer UA; Visvikis-Siest S
    Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
    Wang B; Zeng H; Wen Z; Chen C; Wang DW
    Aging Cell; 2016 Oct; 15(5):940-52. PubMed ID: 27416746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis.
    Zhou C; Huang J; Li Q; Zhan C; Xu X; Zhang X; Ai D; Zhu Y; Wen Z; Wang DW
    Free Radic Biol Med; 2018 Mar; 117():168-179. PubMed ID: 29427791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.
    Aliwarga T; Evangelista EA; Sotoodehnia N; Lemaitre RN; Totah RA
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen.
    Huang A; Sun D
    Front Pharmacol; 2018; 9():1222. PubMed ID: 30420806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.
    Zhao G; Wang J; Xu X; Jing Y; Tu L; Li X; Chen C; Cianflone K; Wang P; Dackor RT; Zeldin DC; Wang DW
    J Lipid Res; 2012 Mar; 53(3):456-466. PubMed ID: 22223859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.